Top former Alnylam exec Barry Greene named CEO of Sage Therapeutics

Jeff Jonas is stepping down as CEO of Sage Therapeutics and will be replaced by longtime Alnylam Pharmaceuticals executive Barry Greene.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.